Pharma R&D Today

Ideas and Insight supporting all stages of Drug Discovery & Development

Select category
Search this blog
Christy J. Wilson

Christy J. Wilson

Sr. Director, Pharma and Biotech Segment

Connect with Christy J. Wilson on LinkedIn
Follow Christy J. Wilson on Twitter
Website:

About the author: Christy brings more than 20 years of global life science and healthcare industry experience to her role as Senior Director, Segment Marketing for the biopharmaceutical industry segment at Elsevier. In this capacity she is focused on understanding biopharmaceutical R&D challenges and the implications for Elsevier in terms of market led growth opportunities that will improve productivity and success for industry executives and their teams. She also plays a key role in increasing Elsevier’s share-of-voice and market share through strategic go-to-market planning and execution. Prior to joining Elsevier, Christy held senior marketing and business development roles in Wolters Kluwer’s Pharma Solutions Business Unit where she was responsible for product management and marketing of the Adis portfolio of drug focused journals and newsletters, pipeline and clinical trials intelligence tools, and pharmacovigilance solutions. During her Wolters Kluwer tenure, Christy also worked in the group’s Healthcare Analytics business, a business that provided powerful data, applications, analytics, and consulting to help companies gain deep insight into the pharmaceutical market. Christy resides in the greater New York City area and holds an MBA in International Business from DePaul University (Chicago) and a BS in Marketing, from Miami University (Ohio).

Posts by Christy J. Wilson

Collaborating to Treat Rare Diseases

Posted on November 16th, 2016 in Pharma R&D

There are about 7,000 diseases out there that are considered “rare,” but they actually affect hundreds of millions of people worldwide – nearly half of whom are children. (more…)

New Hive Participants Tackle Unmet Needs

Posted on October 20th, 2016 in Pharma R&D

When Elsevier R&D Solutions launched its new initiative, dubbed The Hive, earlier this year, its aim was to identify a handful of bright biotech start-ups to participate in a collaborative effort designed to boost early stage drug discovery and development. (more…)

Precompetitive collaboration: Transforming innovation in drug discovery & development

Posted on July 21st, 2016 in Pharma R&D

In 2013, Barbara Mittleman, former director of the Public-Private Partnership Program at the US National Institutes of Health and colleagues assessed the status of precompetitive consortia. (more…)

A gathering of global perspectives… a look at DIA’s annual meeting: Post 2 of 2

Posted on July 18th, 2016 in Pharma R&D

As referenced in my last post, the Drug Information Association (DIA), held its annual conference in Philadelphia at the end of June with this year’s theme being “A Gathering of Global Perspectives.” In follow-up to that post, I want to share with you what I gleaned from two additional noteworthy sessions. (more…)

  1. 1
  2. …
  3. 9
  4. 10
  5. 11
  6. 12
  7. 13
  8. 14